The exact peptide dose
In October 2026, HHS began letting 503A pharmacies compound six peptides. Only KPV and BPC-157 are covered for oral use. We print them as gummies, tablets, capsules, oral films and pellets.
Peptide gummies and tablets
BPC-157 and KPV as layered, single-dose or core-and-shell gummies, tablets or pellets, printed at any strength from one recipe.
Longevity gummy
NAD+ and NMN in one two-layer gummy, at the ratio and strength a clinician prescribes.
Colon-targeted peptides
Patent-pending CORR3CT™ pill-in-pill design holds through the stomach and releases KPV or BPC-157 in the colon.
Compounded products are patient-specific prescriptions and are not FDA-approved. No efficacy claims are made.
3D-printed medicines platform
Precise, room-temperature (no heat, no UV) printing of customized doses on GMP-ready CraftMake™ systems.
CraftMake™ pharmaceutical 3D printer
Dosage forms
P & mini-tablets
Dual-print tablets
Gummies & chewables
Multi-layered tablets
Liquid-embedded chewablesLiquid-core chewables
Multi-layered capsules
Oral dissolvable filmsRelease profiles
Ways to work with us
Bring 3D printing in-house
For 503A pharmacies, hospitals, CDMOs and labs. A CraftMake™ printer with software, training and service included.
CraftMake™ placements →Let us make it
CDMO services include product development, white-label, clinical trial supply and small-batch production.
View CDMO services →Build a product together
Co-development, joint ventures, alliances and licensing of our formulations.
Programs →